News
Displaying 101–110 of 541
-
Foundation News
The May 9th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Foundation News
The free, online event on March 20, 2024, will feature presentations from Rachel Huckfeldt, MD, PhD, Mass Eye and Ear, and Rachelle Lin, OD, Ketchum University.
-
Research News
The company plans to begin a Phase 2/3 clinical trial for the treatment during the first half of 2024.
-
Foundation Fighting Blindness Launches GYROS, a Natural History Study for People with Gyrate Atrophy
Foundation NewsGyrate atrophy is an inherited retinal disease—causing progressive vision loss. GYROS results will help researchers design clinical trials for an emerging gyrate atrophy gene therapy.
-
Ascidian to Launch Clinical Trial for Stargardt Disease RNA Editing Therapy
Research NewsACDN-01 is the only genetic medicine entering clinical development for Stargardt disease.
-
Research News
Known as antisense oligonucleotides, the treatments performed encouragingly in ProQR’s clinical trials
-
Foundation Fighting Blindness Appoints Jeff Klaas as Chief Strategy and Innovation Officer
Foundation NewsKlaas brings over twenty years of experience to lead strategies aimed at elevating engagement and revenue.
-
Kiora Reports Vision Restoration in Phase 1/2 Clinical Trial for Photoswitch Therapy
Research NewsThe company’s molecule is designed to restore some vision to people with ultra-low or no vision caused by advanced retinitis pigmentosa and other retinal diseases.
-
New Report: Vitamin A Supplementation Provides No Vision Benefit to RP Patients
Research NewsThe report also concludes that vitamin E supplementation accelerates vision loss for RP patients
-
Foundation News
First of its Kind Collaboration Marries Genomics Data with World’s Largest Database of Ophthalmologic Patient Encounters to Improve Accuracy of Clinical Research.
